Related Experiment Videos
Defects of mitochondrial DNA
Abstract:
In the past few years several syndromes have been associated with lesions of the human mitochondrial DNA. MtDNA is a small, circular extra-nuclear chromosome encoding essential components of the respiratory chain. MtDNA-related syndromes can be divided into two groups: mitochondrial encephalomyopathies, characterized by the presence of ragged-red fibres (RRF) as the morphological hallmark, or "pure" encephalopathies with no gross morphological abnormalities in muscle. The first group includes myoclonic epilepsy with ragged-red fibres (MERRF), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO) and a new entity, maternally inherited myopathy and cardiomyopathy. The second group includes Leber's Hereditary Optic Neuroretinopathy (LHON) and the newly described ataxia-retinitis pigmentosa-dementia complex. Three kinds of molecular lesions have been identified: point mutations of protein encoding mtDNA-genes (similar to yeast mit- mutations); point mutations of mtDNA-tRNA genes (similar to yeast syn- mutations); and large-scale rearrangements of mtDNA (similar to yeast rho- mutations). In general, "mit-" mutations are responsible for non-RRF encephalopathies, while "syn-" and "rho-" mutations are associated with mitochondrial encephalomyopathies with RRF. Furthermore, point mutations (mit- and syn-) are usually maternally- inherited, while large-scale mtDNA rearrangements are either sporadic or inherited as mendelian traits. In most cases, the molecular detection of the known defects of mtDNA can be carried out by non-invasive techniques, thus making it an easy and relatively inexpensive procedure in the differential diagnosis of the mitochondrial disorders, a rapidly expanding area of clinical neurology.
Insights
Mitochondrial DNA (mtDNA) lesions cause various neurological syndromes. Molecular detection of these defects aids in diagnosing mitochondrial disorders.
Area of Science:
- Genetics and Molecular Biology
- Neurology
- Mitochondrial Medicine
Background:
- Human mitochondrial DNA (mtDNA) encodes crucial respiratory chain components and is linked to several distinct syndromes.
- MtDNA-related disorders are broadly classified into mitochondrial encephalomyopathies with ragged-red fibres (RRF) and "pure" encephalopathies without RRF.
- Examples include MERRF, MELAS, KSS, CPEO, maternally inherited myopathy and cardiomyopathy, LHON, and ataxia-retinitis pigmentosa-dementia complex.
Purpose of the Study:
- To categorize mtDNA-related syndromes based on clinical presentation and underlying molecular pathology.
- To correlate specific types of mtDNA lesions with distinct clinical phenotypes and inheritance patterns.
- To highlight the diagnostic utility of molecular detection for mitochondrial disorders.
Main Methods:
- Classification of syndromes based on morphological hallmarks (RRF) and clinical features.
- Identification of three primary molecular lesion types: point mutations in mtDNA-genes, point mutations in mtDNA-tRNA genes, and large-scale mtDNA rearrangements.
- Analysis of inheritance patterns (maternal, sporadic, Mendelian) associated with different mutation types.
Main Results:
- "Mit-" mutations are generally linked to non-RRF encephalopathies, while "syn-" and "rho-" mutations are associated with RRF-positive mitochondrial encephalomyopathies.
- Point mutations (mit- and syn-) typically exhibit maternal inheritance.
- Large-scale mtDNA rearrangements are often sporadic or follow Mendelian inheritance.
Conclusions:
- Specific molecular defects in mtDNA correlate with distinct clinical syndromes and inheritance patterns.
- Non-invasive molecular testing for mtDNA defects is a valuable and cost-effective tool for diagnosing mitochondrial disorders.
- This diagnostic approach is crucial in the differential diagnosis of an expanding range of clinical neurological conditions.